Pfizer plays hardball in weight-loss drug fight
FT News Briefing
00:00
Why Pfizer Chose Litigation Over Bidding
Oliver discusses strategic reasons Pfizer litigated, including potential political and national-security angles and the possibility of a counteroffer.
Play episode from 05:24
Transcript
